Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
11.15
+0.33 (3.05%)
Jun 2, 2025, 11:02 AM - Market open
Niagen Bioscience Market Cap
Niagen Bioscience has a market cap or net worth of $880.14 million as of June 2, 2025. Its market cap has increased by 218.32% in one year.
Market Cap
880.14M
Enterprise Value
802.15M
1-Year Change
218.32%
Ranking
Category
Stock Price
$11.15
Market Cap Chart
Since June 25, 2008, Niagen Bioscience's market cap has decreased from $909.70M to $880.14M, a decrease of -3.25%. That is a compound annual growth rate of -0.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
May 30, 2025 | 852.30M | 110.34% |
Dec 31, 2024 | 405.20M | 277.28% |
Dec 29, 2023 | 107.40M | -14.15% |
Dec 30, 2022 | 125.10M | -51.02% |
Dec 31, 2021 | 255.40M | -13.89% |
Dec 31, 2020 | 296.60M | 15.50% |
Dec 31, 2019 | 256.80M | 35.87% |
Dec 31, 2018 | 189.00M | -33.29% |
Dec 29, 2017 | 283.30M | 125.74% |
Dec 30, 2016 | 125.50M | -5.71% |
Dec 31, 2015 | 133.10M | 41.45% |
Dec 31, 2014 | 94.10M | -40.97% |
Dec 31, 2013 | 159.40M | 224.64% |
Dec 31, 2012 | 49.10M | 19.76% |
Dec 30, 2011 | 41.00M | -49.88% |
Dec 31, 2010 | 81.80M | 544.09% |
Dec 31, 2009 | 12.70M | -95.35% |
Dec 31, 2008 | 272.90M | -70.00% |
View and export this data all the way back to 2008.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 660.28B |
Johnson & Johnson | 368.37B |
AbbVie | 327.86B |
Novo Nordisk | 305.07B |
UnitedHealth Group | 282.22B |
Abbott Laboratories | 230.84B |
AstraZeneca | 224.00B |
Novartis AG | 223.92B |